Year: 2020
Type: article
Abstract: The plurality of clonogenic cells derived from human lung includes a spectrum of diverse p63+ stem cells responsible for the regeneration of normal epithelial tissue and disease-associated metaplastic lesions. Here, we report protocols for the cloning, expansion, and characterization of these stem cell variants, which in general assist in analyses of stem cell heterogeneity, genome editing, drug screening, and regenerative medicine. For complete details on the use and execution of this protocol, please refer to Kumar et al. (2011), Zuo et al. (2015), and Rao et al. (2020).
Source: STAR Protocols
Institution: University of Houston
Language: English
Topic: Cancer Cells and Metastasis
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,550
Awards: PATIENT SPECIFIC STRATEGIES FOR TARGETING THERAPY-RESISTANT CELLS, Clonal Reconstruction and Targeting of the Correa Sequence, G4471003212, Patient-Matched Stem Cells of the Barrett's-Dysplasia-Adenocarcinoma Sequence, Pathogenic Heterogeneity in Mucosal Stem Cells in Pediatric Crohn's Disease, Recruitment of Rising Stars, Pro-Inflammatory Stem Cell Variants in Cystic Fibrosis
OpenAlex ID: W3041666060
